Fresenius Medical Care AG
XMUN:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
XMUN:FME
Watchlist
Price: 43.5 EUR -1%
Market Cap: 25.5B EUR
Have any thoughts about
Fresenius Medical Care AG?
Write Note
Section:
 

Relative Value

The Relative Value of one FME stock under the Base Case scenario is 62.81 EUR. Compared to the current market price of 43.5 EUR, Fresenius Medical Care AG is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FME Relative Value
Base Case
62.81 EUR
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
55
vs Industry
65
Median 3Y
1.2
Median 5Y
1.8
Industry
2.3
Forward
1.3
More Details
48.1
P/E
P/E
Price to Earnings
48.1
vs History
3
vs Industry
10
Median 3Y
39.3
Median 5Y
34.4
Industry
23.1
Forward
31.5
More Details
12.5
P/OCF
P/OCF
Price to OCF
12.5
vs History
30
vs Industry
38
Median 3Y
10.3
Median 5Y
10.3
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
46.3
Median 5Y
32.6
Industry
20.1
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
57
vs Industry
50
Median 3Y
1.6
Median 5Y
2.5
Industry
2.2
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
58
vs Industry
56
Median 3Y
1.7
Median 5Y
2.3
Industry
2.4
Forward
1.8
More Details
7.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.1
vs History
55
vs Industry
36
Median 3Y
6.5
Median 5Y
7.7
Industry
5
More Details
11.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.2
vs History
55
vs Industry
34
Median 3Y
10.3
Median 5Y
11.6
Industry
12.7
Forward
10.7
More Details
25.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.8
vs History
19
vs Industry
20
Median 3Y
24.5
Median 5Y
23.4
Industry
17.1
Forward
19.7
More Details
17.1
EV/OCF
EV/OCF
Enterprise Value to OCF
17.1
vs History
26
vs Industry
32
Median 3Y
14.8
Median 5Y
14.5
Industry
14
More Details
26.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.1
vs History
30
vs Industry
26
Median 3Y
22.1
Median 5Y
22.1
Industry
18
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
55
vs Industry
60
Median 3Y
1
Median 5Y
1.3
Industry
1.9
More Details

Multiples Across Competitors

FME Competitors Multiples
Fresenius Medical Care AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
AU
Sonic Healthcare Ltd
ASX:SHL
13.1B AUD 1.5 25.6 19.2 19.2
P/E Multiple
Earnings Growth P/E to Growth
DE
Fresenius Medical Care AG
XMUN:FME
Average P/E: 26.8
48.1
127%
0.4
US
Cigna Corp
NYSE:CI
25.9
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.9
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.5
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3
AU
Sonic Healthcare Ltd
ASX:SHL
25.6
37%
0.7

See Also

Summary
FME intrinsic value, competitors valuation, and company profile.
DCF Valuation
FME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FME stock valuation using valuation multiples.
Wall Street Estimates
FME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.